Tumor suppressor gene ZAC/PLAGL1: altered expression and loss of the nonimprinted allele in pheochromocytomas

Cancer Genetics - Tập 204 - Trang 398-404 - 2011
Sonata Jarmalaite1, Aida Laurinaviciene2,3, Justina Tverkuviene1, Neringa Kalinauskaite1, Donatas Petroska3, Tom Böhling4, Kirsti Husgafvel-Pursiainen5
1Faculty of Natural Sciences, Vilnius University, Vilnius, Lithuania
2Institute of Oncology, Vilnius University, Vilnius, Lithuania
3National Centre of Pathology, Vilnius, Lithuania
4Department of Pathology, Helsinki University Central Hospital, HUSLAB, Helsinki, Finland
5Biological Mechanisms and Prevention of Work-Related Diseases, Finnish Institute of Occupational Health, Helsinki, Finland

Tài liệu tham khảo

Karagiannis, 2007, Pheochromocytoma: an update on genetics and management, Endocr Relat Cancer, 14, 935, 10.1677/ERC-07-0142 Salmenkivi, 2004, Malignancy in pheochromocytomas, APMIS, 112, 551, 10.1111/j.1600-0463.2004.apm1120901.x Gimm, 2005, Pheochromocytoma-associated syndromes: genes, proteins and functions of RET, VHL and SDHx, Fam Cancer, 4, 17, 10.1007/s10689-004-5740-1 Dannenberg, 2000, Losses of chromosomes 1p and 3q are early genetic events in the development of sporadic pheochromocytomas, Am J Pathol, 157, 353, 10.1016/S0002-9440(10)64547-6 Lui, 2002, Selective loss of chromosome 11 in pheochromocytomas associated with the VHL syndrome, Oncogene, 21, 1117, 10.1038/sj.onc.1205149 Lemeta, 2006, Frequent loss of heterozygosity at 6q in pheochromocytoma, Hum Pathol, 37, 749, 10.1016/j.humpath.2006.02.002 Lemeta, 2004, Loss of heterozygosity at 6q is frequent and concurrent with 3p loss in sporadic and familial capillary hemangioblastomas, J Neuropathol Exp Neurol, 63, 1072, 10.1093/jnen/63.10.1072 Lemeta, 2002, Recurrent DNA sequence copy losses on chromosomal arm 6q in capillary hemangioblastoma, Cancer Genet Cytogenet, 133, 174, 10.1016/S0165-4608(01)00578-7 Lemeta, 2007, Preferential loss of the nonimprinted allele for the ZAC1 tumor suppressor gene in human capillary hemangioblastoma, J Neuropathol Exp Neurol, 66, 860, 10.1097/nen.0b013e318149ee64 Spengler, 1997, Regulation of apoptosis and cell cycle arrest by Zac1, a novel zinc finger protein expressed in the pituitary gland and the brain, EMBO J, 16, 2814, 10.1093/emboj/16.10.2814 Abdollahi, 1997, Identification of a gene containing zinc-finger motifs based on lost expression in malignantly transformed rat ovarian surface epithelial cells, Cancer Res, 57, 2029 Abdollahi, 2007, LOT1 (ZAC1/PLAGL1) and its family members: mechanisms and functions, J Cell Physiol, 210, 16, 10.1002/jcp.20835 Varrault, 2006, Zac1 regulates an imprinted gene network critically involved in the control of embryonic growth, Dev Cell, 11, 711, 10.1016/j.devcel.2006.09.003 Theodoropoulou, 2010, ZAC1 target genes and pituitary tumorigenesis, Mol Cell Endocrinol, 326, 60, 10.1016/j.mce.2010.01.033 Varrault, 1998, hZAC encodes a zinc finger protein with antiproliferative properties and maps to a chromosomal region frequently lost in cancer, Proc Natl Acad Sci U S A, 95, 8835, 10.1073/pnas.95.15.8835 Bilanges, 1999, Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors, Oncogene, 18, 3979, 10.1038/sj.onc.1202933 Cvetkovic, 2004, Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer, Gynecol Oncol, 95, 449, 10.1016/j.ygyno.2004.08.051 Murillo, 2006, Prostate cancer cells use genetic and epigenetic mechanisms for progression to androgen independence, Genes Chromosomes Cancer, 45, 702, 10.1002/gcc.20333 Pagotto, 2000, The expression of the antiproliferative gene ZAC is lost or highly reduced in nonfunctioning pituitary adenomas, Cancer Res, 60, 6794 Koy, 2004, Loss of expression of ZAC/LOT1 in squamous cell carcinomas of head and neck, Head Neck, 26, 338, 10.1002/hed.10386 Basyuk, 2005, The candidate tumor suppressor gene ZAC is involved in keratinocyte differentiation and its expression is lost in basal cell carcinomas, Mol Cancer Res, 3, 483, 10.1158/1541-7786.MCR-05-0019 Herman, 1996, Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands, Proc Natl Acad Sci U S A, 93, 9821, 10.1073/pnas.93.18.9821 Abdollahi, 2003, LOT1 (PLA GL1/ZAC1), the candidate tumor suppressor gene at chromosome 6q24–25, is epigenetically regulated in cancer, J Biol Chem, 278, 6041, 10.1074/jbc.M210361200 Kamikihara, 2005, Epigenetic silencing of the imprinted gene ZAC by DNA methylation is an early event in the progression of human ovarian cancer, Int J Cancer, 115, 690, 10.1002/ijc.20971 Pandita, 2007, Malignant and benign ganglioglioma: a pathological and molecular study, Neuro Oncol, 9, 124, 10.1215/15228517-2006-029 Valleley, 2007, Tissue-specific imprinting of the ZAC/PLAGL1 tumour suppressor gene results from variable utilization of monoallelic and biallelic promoters, Hum Mol Genet, 6, 972, 10.1093/hmg/ddm041 Valleley, 2010, Loss of expression of ZAC/PLAGL1 in diffuse large B-cell lymphoma is independent of promoter hypermethylation, Genes Chromosomes Cancer, 49, 480 Valente, 2001, Expression pattern of Zac1 mouse gene, a new zinc-finger protein that regulates apoptosis and cellular cycle arrest, in both adult brain and along development, Mech Dev, 108, 207, 10.1016/S0925-4773(01)00492-0 Ciani, 2003, Developmental expression of the cell cycle and apoptosis controlling gene, Lot1, in the rat cerebellum and in cultures of cerebellar granule cells, Brain Res Dev Brain Res, 42, 193, 10.1016/S0165-3806(03)00092-0 Valente, 2004, Zac1 is up-regulated in neural cells of the limbic system of mouse brain following seizures that provoke strong cell activation, Neuroscience, 128, 323, 10.1016/j.neuroscience.2004.06.056